GeneDx Holdings (WGS) Other Non Operating Income (2020 - 2026)

GeneDx Holdings (WGS) has 7 years of Other Non Operating Income data on file, last reported at -$6.6 million in Q1 2026.

• Other Non Operating Income for Q1 2026 came in at -$6.6 million, down 3241.15% year-over-year; the trailing twelve-month figure through Mar 2026 was -$11.1 million (up 13.63% YoY), and the FY2025 annual result was -$4.3 million, up 66.83% from the prior year.
• Other Non Operating Income fell to -$6.6 million in Q1 2026 per WGS's latest filing, from -$4.6 million in the prior quarter.
• Over five years, Other Non Operating Income peaked at $2.7 million in Q1 2023 and troughed at -$13.5 million in Q2 2024.
• A 5-year average of -$1.4 million and a median of $500.0 in 2022 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2023 and 2025: Other Non Operating Income tumbled 56800.0% in 2023, then soared 464.86% in 2025.
• A 5-year view of Other Non Operating Income shows it stood at -$1000.0 in 2022, then sank by 4800.0% to -$49000.0 in 2023, then sank by 1357.14% to -$714000.0 in 2024, then sank by 543.0% to -$4.6 million in 2025, then tumbled by 43.0% to -$6.6 million in 2026.
• Business Quant data shows WGS's Other Non Operating Income at -$6.6 million in Q1 2026, -$4.6 million in Q4 2025, and -$174000.0 in Q3 2025.